Some diabetes device makers fall after Abbott, Medtronic glucose monitoring partnership

Tandem Diabetes Care

07/08/2024 16:03

** Shares of Tandem diabetes care  TNDM.O  fall ~9.9% to
$39.17 
    ** Medical device makers Abbott Laboratories  ABT.N  and
Medtronic  MDT.N  have entered into a partnership to integrate
the former's continuous glucose monitoring (CGM) sensors with
MDT's insulin delivery systems
    ** Insulet's  PODD.O  shares down ~1.2% at $194.05, Dexcom
 DXCM.O  down ~5% at $71.35
    ** "We expect Medtronic's strategic decision to only work
with ABT will weigh on DXCM, and PODD and TNDM as the
partnership is better understood" - Brokerage Citi
    ** Including session's move, DXCM down 41.8%, PODD down
11.1%, TNDM up 31.9% YTD

    

 (Reporting by Christy Santhosh)
 ((Christy.Santhosh@thomsonreuters.com))